BamSEC and AlphaSense Join Forces
Learn More

Kineta Inc.

OTC: KANT    
Share price (1/7/25): $0.35    
Market cap (1/7/25): $4.293 million
Search in Documents
Key Exhibits
External Links

Articles of Incorporation Filter

EX-3.3
from 8-K 28 pages Fourth Amended and Restated By-Laws of Kineta, Inc
12/34/56
EX-3.2
from 8-K 1 page Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation of Yumanity Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation of Yumanity Therapeutics, Inc
12/34/56
EX-3.2
from 8-K 1 page Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation of Proteostasis Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 1 page Certificate of Amendment to the Fifth Amended and Restated Certificate of Incorporation of Proteostasis Therapeutics, Inc
12/34/56
EX-3.1
from 425 15 pages Third Amended and Restated By-Laws of Proteostasis Therapeutics, Inc
12/34/56
EX-3.1
from 8-K 15 pages Third Amended and Restated By-Laws of Proteostasis Therapeutics, Inc
12/34/56
EX-3.1
from S-3 6 pages Fifth Amended and Restated Certificate of Incorporation of Proteostasis Therapeutics, Inc
12/34/56
EX-3.4
from S-1/A 22 pages Second Amended and Restated By-Laws of Proteostasis Therapeutics, Inc
12/34/56
EX-3.2
from S-1/A 6 pages Fifth Amended and Restated Certificate of Incorporation of Proteostasis Therapeutics, Inc
12/34/56
EX-3.1
from S-1/A 28 pages Fourth Amended and Restated Certificate of Incorporation of Proteostasis Therapeutics, Inc. (Pursuant to Sections 242 and 245 of the General Corporation Law of the State of Delaware (The “Dgcl”))
12/34/56
EX-3.3
from S-1 20 pages Proteostasis Therapeutics, Inc. Amended and Restated B Y L a W S
12/34/56
EX-3
from DRS/A 20 pages Proteostasis Therapeutics, Inc. Amended and Restated B Y L a W S
12/34/56